Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), Globalspace Technologies has informed that the Board at its meeting held today Friday, March 08, 2024, through video Conferencing, 1. Considered and approved the appointment of Ankita Kyal (Membership No. A51008) as a Company Secretary & Compliance Officer of the Company. (Annexure A) and 2. Deliberated, considered, and approved acquisition of 51% stake of Innopharm Healthcare (CIN: U74999MH2015PTC267088) by executing a share swap transaction. (Annexure B). The Board Meeting commenced at 12:30 pm and concluded at 01:15 pm.
The above information is a part of company’s filings submitted to BSE.
